GSK Sees Emerging Market Opportunity In Thinking Locally, Developing Locally
U.K. drug maker is increasing its sales forces in emerging markets “very significantly”, even at a time when the company is reducing its sales force in U.S. and Europe.
U.K. drug maker is increasing its sales forces in emerging markets “very significantly”, even at a time when the company is reducing its sales force in U.S. and Europe.